Reuters reports a nicotine addiction pill may help smokers give up smoking over a period of time, when they find it difficult give up smoking suddenly, citing a study published in the Journal of the American Medical Association. According to the study, smokers who used Pfizer Inc.’s medication, called Chantix (varenicline) in the US, can substantially boost the chances of giving up smoking compared with smokers who didn’t take the medicine.
Highlighting the significance of the study, the New York Times reports that “clinical practice guidelines have long advised doctors to have their patients set a precise quit date before prescribing medicine such as Chantix.” The idea, according to the article, “was that such medicine should not be prescribed for someone who is not serious about quitting.” In some cases, “insurance plans would not pay for the pills if no quit date had been set.” Also, the study opens the way “to a much larger population of patients whom doctors could potentially treat,” the paper adds.
From the news release of the American Association for Justice.

